FDA Import Refusal AEK-0113241-3/40002/1 — Naxpar Pharma Pvt. Ltd
The FDA refused shipment AEK-0113241-3/40002/1 from Naxpar Pharma Pvt. Ltd (India) on Mar 30, 2026. The refused product falls under Drugs and Biologics — FEXOFENADINE HCL (ANTI-ASTHMATIC). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Mar 30, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61EDY06 FEXOFENADINE HCL (ANTI-ASTHMATIC)
- Charges
- 75